Research shows how used coffee grounds help cancer treatement
According to new research from Dublin City University, leftover coffee grounds have the potential to deliver anti-cancer drugs to the body.
The study, published in the journal Nanoscale, took used coffee grounds and generated tiny 'carbon dots' from them, using relatively gentle chemical processes.
Advertisement
The scientists then explored their properties, finding signs that these materials could hold promise for future biomedical applications, including drug delivery.
To carry out the study, the team used two widely available brands of coffee and treated the spent coffee grounds to create carbon dots.
The team then analysed the resulting carbon dots using spectroscopy and microscopy, confirming their high quality and uniformity.
'Cancer treatment is advancing all the time, but challenges still remain, including the side-effects of chemotherapy,' explains Prof. Silvia Giordani, whose lab at DCU School of Chemical Sciences led the research.
Advertisement
'This is where we believe that nanomedicine, or using tiny nanoparticles such as carbon dots, could help improve treatment effectiveness and potentially reduce side-effects for patients.'
'There was nothing special about the coffee we used, we just went out and bought it off the shelves in shops in Dublin.
'We were pleased to see that we could upcycle the used coffee grounds into these carbon dots, which hold great potential for many different applications, including drug delivery in the body.
'Treating coffee leftovers in this low-cost way eliminates the need for highly toxic heavy metals and reduces energy-intensive reaction times, and it offers a sustainable route to landfill disposal, helping to reduce environmental harm.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 hours ago
- The Sun
Common food item could lower your risk of heart disease & type 2 diabetes, boffins claim
BUTTER could actually reduce your risk of heart disease, scientists say. Having a teaspoonful a day was found to cut the risk of getting type 2 diabetes by a third. The study, published in the European Journal of Clinical Nutrition, found that butter boosts 'good' cholesterol - which helps to remove harmful fats known to cause heart attacks and strokes. Scientists from Boston University tracked 2,500 men and women over the age of 30 over decades, noting what they ate and how many went on to develop heart disease. Those who ate five grammes of butter a day or more were 31 per cent less likely to develop Type 2 diabetes - usually caused by poor diet and lifestyle - than those eating little or no butter. Margarines - often promoted as 'healthy' alternatives for butter - increased the risk of diabetes by more than 40 per cent and heart problems by 30 per cent. Researchers put it down to the unhealthy 'trans fats' used in margarines from the 1970s onwards - now largely ditched by spread manufacturers. Eating a portion of beans a day could also slash your risk of deadly heart attack or stroke, new research shows. Beans - whether they're dried, canned or frozen - can boost heart and metabolic health, according to scientists. Daily portions of chickpeas and black beans could serve as a "simple, cost-effective" way to reduce the risk of chronic diseases, they said. The new study links chickpeas to improved cholesterol levels, which blacks beans seemed to reduce inflammation.
Daily Mail
2 hours ago
- Daily Mail
Fat jabs 'may stop hormone replacement therapy working and raise cancer risk'
Weight-loss drugs could prevent hormone replacement therapy from working – and put the health of menopausal women at risk. The British Menopause Society (BMS) has advised doctors to closely monitor patients taking HRT for menopause while also using fat jabs such as Mounjaro, Wegovy and Ozempic. Experts say the drugs' ability to delay food's transit through the gut can slow absorption of oral pills. The medicines regulator last week warned that women using fat jabs should not rely on oral contraception after receiving more than 40 reports of pregnancies from those using the two drugs together. Now guidance suggests women taking HRT orally should also be aware of the risks. The most common form of HRT is a progesterone pill alongside a skin patch or gel to deliver oestrogen. Importantly, progesterone balances out the effects of oestrogen, which alone boosts womb lining growth, and can cause 'abnormal cells and cancer '. The BMS, concerned about the potential loss of progesterone's protective effect, has now advised doctors to move women to an intrauterine device, such as a coil, or raise the progesterone dose. Professor Annice Mukherjee, of the society's medical advisory council, who led on the guidance, said an imbalance in hormones, particularly in women with obesity, would put them 'at increased risk of womb cancer'. But she stressed that the biggest risk factor for womb cancer is obesity and so overall the weight-loss jabs were a positive tool to reduce weight and cancer risk. It comes as a GP told the Cheltenham Science Festival patients may need to use fat jabs for life. Professor Graham Easton, who has used them himself, said: 'There's no point in most people taking it for a couple of years and then have the weight bouncing back.' There were 2.6million women taking HRT in 2023/24 in England to help with symptoms of the menopause, which can include hot flushes, night sweats, difficulty sleeping, mood changes, and aches. Meanwhile, more than 1.5million Britons are taking weight-loss jabs, with demand doubling in the past six months. It is not known how many are on both drugs together.
The Independent
3 hours ago
- The Independent
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
Changes in specific bacteria in the mouth and gut of patients with Parkinson's disease could potentially be an early warning sign that symptoms of the condition are getting worse, a study suggests. With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
